A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3
Study sponsor: Hepion Pharmaceuticals, Inc.
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-04-15Actual
Enrollment · participants60Actual
Source updated2024-06-13Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.